Myasthenia gravis (MG) emerges as a critical autoimmune neuromuscular pathology distinguished by fluctuating muscle weakness and premature exhaustion. Contemporary developments over the past decade have delivered unprecedented advances in clinical comprehension, driven by innovative diagnostic methodologies and immunological breakthroughs that have restructured the healthcare industry into a...